These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25787095)
1. Molecular effects of supraphysiological doses of doping agents on health. Imperlini E; Mancini A; Alfieri A; Martone D; Caterino M; Orrù S; Buono P Mol Biosyst; 2015 Jun; 11(6):1494-506. PubMed ID: 25787095 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of DHT and IGF-1 hyperstimulation in human peripheral blood lymphocytes. Imperlini E; Spaziani S; Mancini A; Caterino M; Buono P; Orrù S Proteomics; 2015 Jun; 15(11):1813-8. PubMed ID: 25669835 [TBL] [Abstract][Full Text] [Related]
3. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Ehrnborg C; Ellegård L; Bosaeus I; Bengtsson BA; Rosén T Clin Endocrinol (Oxf); 2005 Apr; 62(4):449-57. PubMed ID: 15807876 [TBL] [Abstract][Full Text] [Related]
4. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. Gosetti F; Mazzucco E; Gennaro MC; Marengo E J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577 [TBL] [Abstract][Full Text] [Related]
5. Impact of physical activity and doping on epigenetic gene regulation. Schwarzenbach H Drug Test Anal; 2011 Oct; 3(10):682-7. PubMed ID: 21671428 [TBL] [Abstract][Full Text] [Related]
6. Physiological and pharmacological basis for the ergogenic effects of growth hormone in elite sports. Ehrnborg C; Rosén T Asian J Androl; 2008 May; 10(3):373-83. PubMed ID: 18385899 [TBL] [Abstract][Full Text] [Related]
7. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? Tentori L; Graziani G Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. Imperlini E; Mancini A; Spaziani S; Martone D; Alfieri A; Gemei M; del Vecchio L; Buono P; Orrù S Proteomics; 2010 Sep; 10(17):3165-75. PubMed ID: 20677326 [TBL] [Abstract][Full Text] [Related]
9. Doping in sport: effects, harm and misconceptions. Birzniece V Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881 [TBL] [Abstract][Full Text] [Related]
10. Use of doping agents, particularly anabolic steroids, in sports and society. Sjöqvist F; Garle M; Rane A Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731 [TBL] [Abstract][Full Text] [Related]
12. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone. Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans. Mauras N; Doi SQ; Shapiro JR J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855 [TBL] [Abstract][Full Text] [Related]
14. [Doping in sports]. Pirnay F Rev Med Liege; 2001 Apr; 56(4):265-8. PubMed ID: 11421166 [TBL] [Abstract][Full Text] [Related]
15. Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Anderson LJ; Tamayose JM; Garcia JM Mol Cell Endocrinol; 2018 Mar; 464():65-74. PubMed ID: 28606865 [TBL] [Abstract][Full Text] [Related]
16. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out]. de Ronde W Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159 [TBL] [Abstract][Full Text] [Related]
17. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports. Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264 [TBL] [Abstract][Full Text] [Related]
18. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids]. Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670 [TBL] [Abstract][Full Text] [Related]
19. New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder. Geraci MJ; Cole M; Davis P Hum Exp Toxicol; 2011 Dec; 30(12):2007-12. PubMed ID: 21558143 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes. Spaziani S; Imperlini E; Mancini A; Caterino M; Buono P; Orrù S Proteomics; 2014 Jul; 14(13-14):1623-9. PubMed ID: 24753496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]